CDKN2A and glioblastoma: Matching with these findings, the current study found “deep deletion” as the most common form of the genetic alterations that occur to CDKN2A under tumor conditions where the assessment of alteration frequency in tumors, including GBM, MESO, SARC, and THYM, demonstrated “deep deletion” as almost the only form of investigated alterations.